HTL Biotechnology joins the Choiseul Conquérants 2025 ranking
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
We were thrilled to have been a Gold sponsor at the SFB conference this year.
Our business manager, Patrick McDaniel, our Chief Scientific Officer, Anthony Bresin, our Innovation Project Manager, Mélanie Leroux, and our partner Echelon Biosciences were all in attendance, seeking opportunities to connect with other professionals in the field of Tissue Engineering & Regenerative Medicine.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.